4-Methyl-3-nitrobenzonitrile | CAS:939-79-7

We serve 4-Methyl-3-nitrobenzonitrile CAS:939-79-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Methyl-3-nitrobenzonitrile

Chemical Name:4-Methyl-3-nitrobenzonitrile
CAS.NO:939-79-7
Synonyms:4-Methyl-3-nitrobenzonitrile
3-Nitro-4-methylbenzonitrile
4-methyl-3-nitro benzonitrile
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 282.0±28.0 °C at 760 mmHg
Melting Point 102-106 °C(lit.)
Molecular Formula C8H6N2O2
Molecular Weight 162.145
Flash Point 124.3±24.0 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.568
 
Specification:
Appearance:Light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Methyl-3-nitrobenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methyl-3-nitro benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methyl-3-nitro benzonitrile Use and application,4-Methyl-3-nitrobenzonitrile technical grade,usp/ep/jp grade.


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow.(2S,6aS)-Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.5-Bromo-1-pentene supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole vendor ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.